{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:15:11Z","timestamp":1789028111284,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100030841","name":"Exact Sciences Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-025-04997-5","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:11:04Z","timestamp":1757981464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adherence to multi-target stool DNA colorectal cancer screening and clinical follow-up in the Hartford HealthCare system"],"prefix":"10.1007","volume":"40","author":[{"given":"Shrey","family":"Gohil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"D\u2019Attilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchir","family":"Paladiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arup","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunegundo Manuel","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Karlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallik","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"4997_CR1","unstructured":"American Cancer Society. Cancer Facts & Figures 2024. [cited 2025 Apr 1]. Available from: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2024-cancer-facts-figures.html"},{"key":"4997_CR2","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB et al (2021) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 325:1965\u20131977","DOI":"10.1001\/jama.2021.6238"},{"key":"4997_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.gastro.2024.03.011","volume":"167","author":"U Ladabaum","year":"2024","unstructured":"Ladabaum U, Mannalithara A, Weng Y, Schoen RE, Dominitz JA, Desai M et al (2024) Comparative effectiveness and cost-effectiveness of colorectal cancer screening with blood-based biomarkers (liquid biopsy) vs fecal tests or colonoscopy. Gastroenterology 167:378\u2013391","journal-title":"Gastroenterology"},{"key":"4997_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1158\/1940-6207.CAPR-19-0527","volume":"13","author":"A Piscitello","year":"2020","unstructured":"Piscitello A, Edwards DK 5th (2020) Estimating the screening-eligible population size, ages 45\u201374, at average risk to develop colorectal cancer in the United States. Cancer Prev Res (Phila) 13:443\u2013448","journal-title":"Cancer Prev Res (Phila)"},{"key":"4997_CR5","unstructured":"Office of Disease Prevention and Health Promotion (2023) Increase the proportion of adults who get screened for colorectal cancer. [cited 2024 Dec 19]. Available from:  https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/cancer\/increase-proportion-adults-who-get-screened-colorectal-cancer-c-07"},{"key":"4997_CR6","first-page":"250","volume":"68","author":"AMD Wolf","year":"2018","unstructured":"Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ et al (2018) Colorectal cancer screening for average\u2010risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 68:250\u2013281","journal-title":"CA Cancer J Clin"},{"key":"4997_CR7","unstructured":"Centers for Disease Control and Prevention (CDC) (2024) Use of colorectal cancer screening tests. Available from: https:\/\/www.cdc.gov\/colorectal-cancer\/use-screening-tests\/index.html. cited 2024 May 22"},{"key":"4997_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","volume":"370","author":"TF Imperiale","year":"2014","unstructured":"Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP et al (2014) Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370:1287\u20131297","journal-title":"N Engl J Med"},{"key":"4997_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.14309\/ajg.0000000000000445","volume":"114","author":"LJW Bosch","year":"2019","unstructured":"Bosch LJW, Melotte V, Mongera S, Daenen KLJ, Coup\u00e9 VMH, van Turenhout ST et al (2019) Multitarget stool DNA test performance in an average-risk colorectal cancer screening population. Am J Gastroenterol 114:1909\u20131918","journal-title":"Am J Gastroenterol"},{"key":"4997_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22269","volume":"4","author":"DA Fisher","year":"2021","unstructured":"Fisher DA, Princic N, Miller-Wilson LA, Wilson K, Fendrick AM, Limburg P (2021) Utilization of a colorectal cancer screening test among individuals with average risk. JAMA Netw Open 4:e2122269","journal-title":"JAMA Netw Open"},{"key":"4997_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/03007995.2021.1879754","volume":"37","author":"PJ Limburg","year":"2021","unstructured":"Limburg PJ, Finney Rutten LJ, Ozbay AB, Kisiel J, Parton M (2021) Recent trends in colorectal cancer screening methods based on Medicare claims data. Curr Med Res Opin 37:605\u2013607","journal-title":"Curr Med Res Opin"},{"key":"4997_CR12","unstructured":"Centers for Disease Control and Prevention (CDC). Screening for colorectal cancer. [cited 2024 Dec 10]. Available from: https:\/\/www.cdc.gov\/colorectal-cancer\/screening\/index.html"},{"key":"4997_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2020.101202","volume":"20","author":"LJ Finney Rutten","year":"2020","unstructured":"Finney Rutten LJ, Jacobson DJ, Jenkins GD, Fan C, Weiser E, Parks P et al (2020) Colorectal cancer screening completion: an examination of differences by screening modality. Prev Med Rep 20:101202","journal-title":"Prev Med Rep"},{"key":"4997_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/03007995.2024.2303090","volume":"40","author":"C Cheney","year":"2024","unstructured":"Cheney C, Parish A, Niedzwiecki D, Oko C, Walters C, Halpern D et al (2024) Colorectal cancer screening uptake and adherence by modality at a large tertiary care center in the United States: a retrospective analysis. Curr Med Res Opin 40:431\u2013439","journal-title":"Curr Med Res Opin"},{"key":"4997_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00384-025-04805-0","volume":"40","author":"QA Le","year":"2025","unstructured":"Le QA, Greene M, Gohil S, Ozbay AB, Dore M, Fendrick AM et al (2025) Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States. Int J Colorectal Dis 40:16","journal-title":"Int J Colorectal Dis"},{"key":"4997_CR16","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s00384-021-03956-0","volume":"36","author":"LA Miller-Wilson","year":"2021","unstructured":"Miller-Wilson LA, Rutten LJF, Van Thomme J, Ozbay AB, Limburg PJ (2021) Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort. Int J Colorectal Dis 36:2471\u20132480","journal-title":"Int J Colorectal Dis"},{"key":"4997_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/14737167.2023.2220965","volume":"23","author":"NM Engel-Nitz","year":"2023","unstructured":"Engel-Nitz NM, Miller-Wilson LA, Le L, Fisher DA (2023) Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening. Expert Rev Pharmacoecon Outcomes Res 23:843\u2013852","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4997_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.2693","volume":"7","author":"EL Ciemins","year":"2024","unstructured":"Ciemins EL, Mohl JT, Moreno CA, Colangelo F, Smith RA, Barton M (2024) Development of a follow-up measure to ensure complete screening for colorectal cancer. JAMA Netw Open 7:e242693","journal-title":"JAMA Netw Open"},{"key":"4997_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51384","volume":"6","author":"JT Mohl","year":"2023","unstructured":"Mohl JT, Ciemins EL, Miller-Wilson LA, Gillen A, Luo R, Colangelo F (2023) Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017\u20132020. JAMA Netw Open 6:e2251384","journal-title":"JAMA Netw Open"},{"key":"4997_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3122\/jabfm.2021.01.200345","volume":"34","author":"GS Cooper","year":"2021","unstructured":"Cooper GS, Grimes A, Werner J, Cao S, Fu P, Stange KC (2021) Barriers to follow-up colonoscopy after positive FIT or multitarget stool DNA testing. J Am Board Fam Med 34:61\u201369","journal-title":"J Am Board Fam Med"},{"key":"4997_CR21","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.2016.5989","volume":"315","author":"K Bibbins-Domingo","year":"2016","unstructured":"US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr et al (2016) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315:2564\u20132575","journal-title":"JAMA"},{"key":"4997_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.hoc.2022.02.005","volume":"36","author":"P Dharwadkar","year":"2022","unstructured":"Dharwadkar P, Zaki TA, Murphy CC (2022) Colorectal cancer in younger adults. Hematol Oncol Clin North Am 36:449\u2013470","journal-title":"Hematol Oncol Clin North Am"},{"key":"4997_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1848","volume":"7","author":"EM Montminy","year":"2024","unstructured":"Montminy EM, Zhou M, Edelson JC, Karlitz JJ (2024) Stage-stratified incidence rates of colorectal adenocarcinoma among patients aged 46 to 49 in the United States. JAMA Netw Open 7:e241848\u2013e","journal-title":"JAMA Netw Open"},{"key":"4997_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/1878-0261.12417","volume":"13","author":"G Mauri","year":"2019","unstructured":"Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S (2019) Early-onset colorectal cancer in young individuals. Mol Oncol 13:109\u2013131","journal-title":"Mol Oncol"},{"key":"4997_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00384-025-04837-6","volume":"40","author":"M Greene","year":"2025","unstructured":"Greene M, Pew T, Dore M, Ebner DW, Ozbay AB, Johnson WK et al (2025) Re-screening adherence to multi-target stool DNA test for colorectal cancer: real-world study in a large national population. Int J Colorectal Dis 40:48","journal-title":"Int J Colorectal Dis"},{"key":"4997_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/tbm\/ibab079","volume":"12","author":"T Hyams","year":"2022","unstructured":"Hyams T, Mueller N, Curbow B, King-Marshall E, Sultan S (2022) Screening for colorectal cancer in people ages 45\u201349: research gaps, challenges and future directions for research and practice. Transl Behav Med 12:198\u2013202","journal-title":"Transl Behav Med"},{"key":"4997_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/1073274819825828","volume":"26","author":"R Azulay","year":"2019","unstructured":"Azulay R, Valinsky L, Hershkowitz F, Magnezi R (2019) CRC screening results: patient comprehension and follow-up. Cancer Control 26:1073274819825828","journal-title":"Cancer Control"},{"key":"4997_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s13187-024-02479-w","volume":"40","author":"X Zhu","year":"2025","unstructured":"Zhu X, Squiers L, Madson G, Helmueller L, Southwell BG, Alam S et al (2025) Patient-provider communication and colorectal cancer screening completion using multi-target stool DNA testing. J Cancer Educ 40:115\u2013123","journal-title":"J Cancer Educ"},{"key":"4997_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59032-0","volume":"10","author":"EA O\u2019Connor","year":"2020","unstructured":"O\u2019Connor EA, Nielson CM, Petrik AF, Green BB, Coronado GD (2020) Prospective cohort study of predictors of follow-up diagnostic colonoscopy from a pragmatic trial of FIT screening. Sci Rep 10:2441","journal-title":"Sci Rep"},{"key":"4997_CR30","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000307","volume":"12","author":"GE Idos","year":"2021","unstructured":"Idos GE, Bonner JD, Haghighat S, Gainey C, Shen S, Mulgonkar A et al (2021) Bridging the gap: patient navigation increases colonoscopy follow-up after abnormal FIT. Clin Transl Gastroenterol 12:e00307","journal-title":"Clin Transl Gastroenterol"},{"key":"4997_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12876-021-01923-1","volume":"21","author":"GD Coronado","year":"2021","unstructured":"Coronado GD, Kihn-Stang A, Slaughter MT, Petrik AF, Thompson JH, Rivelli JS et al (2021) Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process. BMC Gastroenterol 21:356","journal-title":"BMC Gastroenterol"},{"key":"4997_CR32","doi-asserted-by":"publisher","first-page":"E985","DOI":"10.1055\/a-1196-1711","volume":"8","author":"S Cadoni","year":"2020","unstructured":"Cadoni S, Ishaq S, Hassan C, Bhandari P, Neumann H, Kuwai T et al (2020) Covid-19 pandemic impact on colonoscopy service and suggestions for managing recovery. Endosc Int Open 8:E985\u2013E989","journal-title":"Endosc Int Open"},{"key":"4997_CR33","doi-asserted-by":"crossref","unstructured":"Forbes N, Hilsden RJ, Martel M, Ruan Y, Dube C, Rostom A et al (2021) Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes: a systematic review. Clin Gastroenterol Hepatol 19:1344\u201354.e8","DOI":"10.1016\/j.cgh.2020.09.048"},{"key":"4997_CR34","doi-asserted-by":"publisher","first-page":"102032","DOI":"10.1016\/j.pmedr.2022.102032","volume":"30","author":"LA Miller-Wilson","year":"2022","unstructured":"Miller-Wilson LA, Finney Rutten LJ, Van Thomme J, Burak Ozbay A, Laffin J, Limburg P (2022) Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a Medicaid population. Prev Med Rep 30:102032","journal-title":"Prev Med Rep"},{"key":"4997_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/1055-9965.EPI-16-0976","volume":"26","author":"HY Pan","year":"2017","unstructured":"Pan HY, Walker GV, Grant SR, Allen PK, Jiang J, Guadagnolo BA et al (2017) Insurance status and racial disparities in cancer-specific mortality in the United States: a population-based analysis. Cancer Epidemiol Biomarkers Prev 26:869\u2013875","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4997_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ajpath.2017.07.023","volume":"188","author":"GJ Augustus","year":"2018","unstructured":"Augustus GJ, Ellis NA (2018) Colorectal cancer disparity in African Americans: risk factors and carcinogenic mechanisms. Am J Pathol 188:291\u2013303","journal-title":"Am J Pathol"},{"key":"4997_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/bs.acr.2021.02.007","volume":"151","author":"JM Carethers","year":"2021","unstructured":"Carethers JM (2021) Racial and ethnic disparities in colorectal cancer incidence and mortality. Adv Cancer Res 151:197\u2013229","journal-title":"Adv Cancer Res"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-04997-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:11:10Z","timestamp":1757981470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-04997-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4997"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-04997-5","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was considered exempt research under 45 CFR \u00a7 46.104(d)(4) as it involved only the secondary use of data that was de-identified in compliance with the US Health Insurance Portability and Accountability Act of 1996, specifically, 45 CFR \u00a7 164.514.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable; retrospective review of de-identified data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"S. Gohil, D. D\u2019Attilio, J.J. Karlitz, and M. Greene are employees of Exact Sciences Corporation and own stock\/stock options. R. Paladiya, A. Ganguly, and C.M. Vergara report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}